On-Demand ICS + FABA Combinations in 6–11-Year-Old Children

In recent years, some new concepts have been added to asthma treatment such as “anti-inflammatory reliever” (β2-agonist use associated to an inhaled corticosteroid (ICS) as a reliever treatment) that combines the benefits of both therapies and provides short- and long-term benefits for treatment in...

Full description

Bibliographic Details
Main Authors: Elsy M. Navarrete-Rodríguez, Blanca E. Del-Rio-Navarro, Désirée Larenas-Linnemann, Jose A. Castro-Rodriguez
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/12/23/7270

Similar Items